医学
外科
节点(物理)
生物医学工程
结构工程
工程类
作者
P. Wignarajah,Parto Forouhi
出处
期刊:The Breast
[Elsevier BV]
日期:2023-03-14
卷期号:68: S112-S113
标识
DOI:10.1016/s0960-9776(23)00362-4
摘要
effects related to residual immunogenic biologic material and the productive process itself; for this reason, it is necessary to increase knowledge on tissue inflammation, integration, and remodeling mechanisms.The aim of the study is to assess safety, tolerability, and efficacy of this new APM analyzing ultrasonographic and clinical data Methods: We performed a prospective observational study using Exashape® for the reconstruction surgery of patients subjected to mastectomy in both dual-plane and prepectoral setting.The primary objective of the study was to evaluate the APM's safety, comparing major and minor complication rates of the two study groups (Exashape® prepectoral, group A, Exashape® dual plane, group B).Secondary objectives were evaluation of tolerability and efficacy Results: We performed 10 mastectomies followed by reconstruction between 2020 and 2022, for a total of 14 breast implants and 14 APM (9 dual-plane and 5 prepectoral).With a mean follow-up of 13,7 months Finally, in our in vivo ultrasound integration study showed good and predictable integration process in a 12 month period with progressive neovascularization and balancing of viscoelastic properties with superficial tissues, without the development of excessive fibrosis ( periprosthetic capsule) Conclusion(s): Despite the limited number of patients, our data suggested that breast prosthetic reconstruction with Exashape® APM is a valuable and safe alternative in selected patients, both in the dual plane and the prepectoral settings.Moreover, our clinical and ultrasonographic data could be the base for future studies, leading to a better understanding of biological mesh remodeling and integration process, since the balance of degradation and rebuilding process (inflammation/integration) is the key point in the clinical use of these materials.
科研通智能强力驱动
Strongly Powered by AbleSci AI